Evidence map›Paper›PMID 24957626›Full record

ArticleJournal of bacteriology2014

Accumulation of phosphatidic acid increases vancomycin resistance in Escherichia coli.

Holly A Sutterlin, Sisi Zhang, Thomas J Silhavy

Abstract read
In one paragraph

Article in Journal of bacteriology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Unique Regulation of Sed-1 β-Lactamase inAntibiotics (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Effects of pleiotropicJournal of bacteriology · 2024
    Article
  6. Review
  7. Cardiolipin aids in lipopolysaccharide transport to the gram-negative outer membrane.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Holly A SutterlinDepartment of Molecular Biology, Princeton University, Princeton, New Jersey, USA.
Sisi ZhangLewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, New Jersey, USA.
Thomas J SilhavyDepartment of Molecular Biology, Princeton University, Princeton, New Jersey, USA tsilhavy@exchange.Princeton.EDU.

Funding

Spatial Patterning During DevelopmentP50GM071508 · NIGMS · PRINCETON UNIVERSITY · PI POWELL, SUSAN M · 2004 to 2013
$30.6M
PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM007388 · NIGMS · PRINCETON UNIVERSITY · PI CRISTEA, ILEANA M. · 1985 to 2022
$27.4M
GENETIC ANALYSIS OF PROTEIN EXPORTR37GM034821 · NIGMS · PRINCETON UNIVERSITY · PI SILHAVY, THOMAS J. · 1999 to 2008
$4.9M
GENETIC ANALYSIS OF PROTEIN EXPORTR01GM034821 · NIGMS · PRINCETON UNIVERSITY · PI SILHAVY, THOMAS J. · 1985 to 2015
$4.7M
NIGMS NIH HHS GM34821NIGMS NIH HHS P50 GM071508NIGMS NIH HHS R01 GM034821NIGMS NIH HHS R37 GM034821NIGMS NIH HHS T32 GM007388
6 · The paper itself

Abstract

In Gram-negative bacteria, lipopolysaccharide (LPS) contributes to the robust permeability barrier of the outer membrane, preventing entry of toxic molecules such as antibiotics. Mutations in lptD, the beta-barrel component of the LPS transport and assembly machinery, compromise LPS assembly and result in increased antibiotic sensitivity. Here, we report rare vancomycin-resistant suppressors that improve barrier function of a subset of lptD mutations. We find that all seven suppressors analyzed mapped to the essential gene cdsA, which is responsible for the conversion of phosphatidic acid to CDP-diacylglycerol in phospholipid biosynthesis. These cdsA mutations cause a partial loss of function and, as expected, accumulate phosphatidic acid. We show that this suppression is not confined to mutations that cause defects in outer membrane biogenesis but rather that these cdsA mutations confer a general increase in vancomycin resistance, even in a wild-type cell. We use genetics and quadrupole time of flight (Q-TOF) liquid chromatography-mass spectrometry (LC-MS) to show that accumulation of phosphatidic acid by means other than cdsA mutations also increases resistance to vancomycin. We suggest that increased levels of phosphatidic acid change the physical properties of the outer membrane to impede entry of vancomycin into the periplasm, hindering access to its target, an intermediate required for the synthesis of the peptidoglycan cell wall.

Indexed as

Vancomycin Resistance1-Acylglycerol-3-Phosphate O-AcyltransferaseAnti-Bacterial AgentsBacterial Outer Membrane ProteinsChromatography, LiquidEscherichia coliEscherichia coli ProteinsGene Expression Regulation, BacterialMass SpectrometryMutationNucleotidyltransferasesPhosphatidic AcidsPhospholipidsVancomycin1-Acylglycerol-3-Phosphate O-AcyltransferaseAnti-Bacterial AgentsBacterial Outer Membrane ProteinsEscherichia coli ProteinsLptD protein, E coliNucleotidyltransferasesphosphatidate cytidylyltransferasePhosphatidic AcidsPhospholipidsplsC protein, E coliVancomycin

Identifiers

PMID24957626
PMCPMC4135694

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.